As part of the Strafford Publications’ webinar series, Finnegan partners Adriana Burgy, Mark Feldstein, Thomas Irving, and Jill MacAlpine will provide guidance on recent Orange Book developments and implications for patent prosecution, listing, and litigation. They will also examine Form 3542 and pitfalls to avoid. For more information, or to register, please see Strafford’s website.
Food and Drug Administration (FDA), Manual of Patent Examining Procedure (MPEP), Orange Book, Form 3542, Pharmaceutical Patents, patent application, Patent Trial and Appeal Board (PTAB), patentability, United States Court of Appeals for the Federal Circuit (CAFC), United States Patent and Trademark Office (USPTO), drugs
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
INCONTESTABLE® Blog
The Federal Circuit’s Heartfelt Affirmation of Everybody’s Right to Use “Everybody vs. Racism”
March 22, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.